• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色素痣和内分泌腺肿瘤:值得注意和(不那么)罕见的关联。

Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.

机构信息

Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, Lille, France.

University of Lille, Lille, France.

出版信息

Front Endocrinol (Lausanne). 2021 May 6;12:678869. doi: 10.3389/fendo.2021.678869. eCollection 2021.

DOI:10.3389/fendo.2021.678869
PMID:34025587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8134657/
Abstract

Phakomatoses encompass a group of rare genetic diseases, such as von Hippel-Lindau syndrome (VHL), neurofibromatosis type 1 (NF1), tuberous sclerosis complex (TSC) and Cowden syndrome (CS). These disorders are due to molecular abnormalities on the RAS-PI3K-Akt-mTOR pathway for NF1, TSC and CS, and to hypoxia sensing for VHL. Phakomatoses share some phenotypic traits such as neurological, ophthalmological and cutaneous features. Patients with these diseases are also predisposed to developing multiple endocrine tissue tumors, e.g., pheochromocytomas/paragangliomas are frequent in VHL and NF1. All forms of phakomatoses except CS may be associated with digestive neuroendocrine tumors. More rarely, thyroid cancer and pituitary or parathyroid adenomas have been reported. These susceptibilities are noteworthy, because their occurrence rate, prognosis and management differ slightly from the sporadic forms. The aim of this review is to summarize current knowledge on endocrine glands tumors associated with VHL, NF1, TSC, and CS, especially neuroendocrine tumors and pheochromocytomas/paragangliomas. We particularly detail recent advances concerning prognosis and management, especially parenchyma-sparing surgery and medical targeted therapies such as mTOR, MEK and HIF-2 α inhibitors, which have shown truly encouraging results.

摘要

痣样病变包括一组罕见的遗传疾病,如 von Hippel-Lindau 综合征 (VHL)、神经纤维瘤病 1 型 (NF1)、结节性硬化症 (TSC) 和考登综合征 (CS)。这些疾病是由于 NF1、TSC 和 CS 的 RAS-PI3K-Akt-mTOR 通路和 VHL 的缺氧感应的分子异常引起的。痣样病变具有一些表型特征,如神经、眼科和皮肤特征。这些疾病的患者也易发生多种内分泌组织肿瘤,例如嗜铬细胞瘤/副神经节瘤在 VHL 和 NF1 中很常见。除 CS 外,所有形式的痣样病变都可能与消化道神经内分泌肿瘤有关。更罕见的是,甲状腺癌和垂体或甲状旁腺腺瘤也有报道。这些易感性值得注意,因为它们的发生率、预后和管理与散发性形式略有不同。本文综述的目的是总结与 VHL、NF1、TSC 和 CS 相关的内分泌腺体肿瘤的最新知识,特别是神经内分泌肿瘤和嗜铬细胞瘤/副神经节瘤。我们特别详细介绍了最近在预后和管理方面的进展,特别是保留实质的手术和针对 mTOR、MEK 和 HIF-2α抑制剂等的医学靶向治疗,这些治疗方法取得了非常令人鼓舞的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/6ff64f629dfc/fendo-12-678869-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/6d298de3928a/fendo-12-678869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/4505414e0e60/fendo-12-678869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/3abf98118568/fendo-12-678869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/6ff64f629dfc/fendo-12-678869-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/6d298de3928a/fendo-12-678869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/4505414e0e60/fendo-12-678869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/3abf98118568/fendo-12-678869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2f/8134657/6ff64f629dfc/fendo-12-678869-g004.jpg

相似文献

1
Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.色素痣和内分泌腺肿瘤:值得注意和(不那么)罕见的关联。
Front Endocrinol (Lausanne). 2021 May 6;12:678869. doi: 10.3389/fendo.2021.678869. eCollection 2021.
2
Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes.1 型神经纤维瘤病、结节性硬化症及相关综合征中的内分泌肿瘤。
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):439-49. doi: 10.1016/j.beem.2010.02.002.
3
[Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].[胃肠胰和胸部神经内分泌肿瘤的遗传性肿瘤综合征]
Ann Pathol. 2020 Apr;40(2):120-133. doi: 10.1016/j.annpat.2020.01.002. Epub 2020 Feb 5.
4
[Phacomatosis and genetically determined tumors: the transition from childhood to adulthood].[色素沉着息肉综合征与遗传性肿瘤:从儿童期到成年期的转变]
Neurochirurgie. 2008 Oct;54(5):642-53. doi: 10.1016/j.neuchi.2008.07.004. Epub 2008 Aug 26.
5
Pathophysiology and management of glaucoma associated with phakomatoses.与神经皮肤综合征相关的青光眼的病理生理学和治疗。
J Neurosci Res. 2019 Jan;97(1):57-69. doi: 10.1002/jnr.24241. Epub 2018 Apr 1.
6
Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease.神经纤维瘤病 1 型、2 型、结节性硬化症和 von Hippel-Lindau 病。
Childs Nerv Syst. 2023 Oct;39(10):2791-2806. doi: 10.1007/s00381-023-06160-3. Epub 2023 Oct 11.
7
Familial pheochromocytomas and paragangliomas: stories from the sign-out room.家族性嗜铬细胞瘤和副神经节瘤:病例讨论室里的故事
Endocr Pathol. 2006 Winter;17(4):337-44. doi: 10.1007/s12022-006-0005-1.
8
Phakomatoses.斑痣病。
Dermatol Clin. 2019 Oct;37(4):583-606. doi: 10.1016/j.det.2019.05.015.
9
[CNS manifestations of neurocutaneous syndromes].[神经皮肤综合征的中枢神经系统表现]
Radiologe. 2018 Jul;58(7):664-667. doi: 10.1007/s00117-018-0413-5.
10
[Congenital neoplasms].[先天性肿瘤]
Pol J Pathol. 2001;52(4 Suppl):191-203.

引用本文的文献

1
Epigenetic Insights into Tuberous Sclerosis Complex, Von Hippel-Lindau Syndrome, and Ataxia-Telangiectasia.结节性硬化症、冯·希佩尔-林道综合征和共济失调-毛细血管扩张症的表观遗传学见解
Epigenomes. 2025 Jun 9;9(2):20. doi: 10.3390/epigenomes9020020.
2
Association of pituitary neuroendocrine tumors and neurofibromatosis type 1: assessing causation versus coincidence. Case report.垂体神经内分泌肿瘤与1型神经纤维瘤病的关联:评估因果关系与巧合。病例报告。
Front Endocrinol (Lausanne). 2025 Feb 4;16:1483305. doi: 10.3389/fendo.2025.1483305. eCollection 2025.
3
Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1.

本文引用的文献

1
Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.神经纤维瘤病 1 型患者神经鞘瘤中 18F-FDG PET/CT 的局限性和优势:一项横断面/纵向研究。
Cancer Sci. 2021 Mar;112(3):1114-1122. doi: 10.1111/cas.14802. Epub 2021 Jan 22.
2
Why did they change that? Practical implications of the evolving classification of neuroendocrine tumours of the gastrointestinal tract.为什么要做出这样的改变?胃肠道神经内分泌肿瘤分类演变的实际意义。
Histopathology. 2021 Jan;78(1):162-170. doi: 10.1111/his.14172.
3
Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature.
108例接受系统筛查的1型神经纤维瘤病患者的内分泌表现及胃肠道间质瘤患病率
J Endocr Soc. 2023 Jun 17;7(8):bvad083. doi: 10.1210/jendso/bvad083. eCollection 2023 Jul 3.
4
Hypoxia signaling pathway: A central mediator in endocrine tumors.缺氧信号通路:内分泌肿瘤的核心介质
Front Endocrinol (Lausanne). 2023 Jan 9;13:1103075. doi: 10.3389/fendo.2022.1103075. eCollection 2022.
《妊娠合并嗜铬细胞瘤:一项多中心回顾性队列研究和文献系统评价》。
Lancet Diabetes Endocrinol. 2021 Jan;9(1):13-21. doi: 10.1016/S2213-8587(20)30363-6. Epub 2020 Nov 26.
4
Risk factors for new-onset diabetes mellitus after distal pancreatectomy.远端胰腺切除术后新发糖尿病的危险因素。
BMJ Open Diabetes Res Care. 2020 Oct;8(2). doi: 10.1136/bmjdrc-2020-001778.
5
Preoperative Management of Pheochromocytoma and Paraganglioma.《嗜铬细胞瘤和副神经节瘤的术前管理》。
Front Endocrinol (Lausanne). 2020 Sep 29;11:586795. doi: 10.3389/fendo.2020.586795. eCollection 2020.
6
Occurrence and Natural History of Thyroid Cancer in Patients with Cowden Syndrome.考登综合征患者甲状腺癌的发生情况及自然病史。
Eur Thyroid J. 2020 Sep;9(5):243-246. doi: 10.1159/000506422. Epub 2020 Mar 12.
7
Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome.关于PTEN错构瘤综合征患儿分化型甲状腺癌监测的建议。
Eur Thyroid J. 2020 Sep;9(5):234-242. doi: 10.1159/000508872. Epub 2020 Jul 28.
8
Targeting the HIF2-VEGF axis in renal cell carcinoma.靶向肾细胞癌中的 HIF2-VEGF 轴。
Nat Med. 2020 Oct;26(10):1519-1530. doi: 10.1038/s41591-020-1093-z. Epub 2020 Oct 5.
9
Acute Stress Cardiomyopathy: Heart of pheochromocytoma.急性应激性心肌病:嗜铬细胞瘤的心脏。
Ann Endocrinol (Paris). 2021 Jun;82(3-4):201-205. doi: 10.1016/j.ando.2020.03.011. Epub 2020 Mar 18.
10
Somatostatinoma: Beyond neurofibromatosis type 1 (Review).生长抑素瘤:超越1型神经纤维瘤病(综述)
Exp Ther Med. 2020 Oct;20(4):3383-3388. doi: 10.3892/etm.2020.8965. Epub 2020 Jul 3.